Adamantane derivatives enhancing body's resistance to emergencies]
Morozov IS, Klimova NV, Sergeeva SA, Ivanova IA, Barchukov VG, Kovalev GI, Piatin BM, Avdiunina NI · 1999 · Vestnik Rossiiskoi akademii meditsinskikh nauk (3):28-32. PMID 10222828
What does this source report?
Summarizes screening of adamantane derivatives and distinguishes Bromantane from the chemically different Chlodantane.
- Population and setting
- Experimental adamantane-development program and animal stress models
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- A development-program summary is not an independent human trial.
- Historical claims about specific military deployments need their own contemporary documentation.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Morozov IS, Klimova NV, Sergeeva SA, Ivanova IA, Barchukov VG, Kovalev GI, Piatin BM, Avdiunina NI. Adamantane derivatives enhancing body's resistance to emergencies] Vestnik Rossiiskoi akademii meditsinskikh nauk (3):28-32. PMID 10222828 1999.
Molekul research summary: https://molekul.io/research/acto-10222828. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry